Terms: = Kidney tumors AND LDH AND Clinical Outcome
1 results:
1. Serum Lactate Dehydrogenase Before Nivolumab Treatment Could Be a Therapeutic Prognostic Biomarker for Patients With Metastatic Clear Cell Renal Cell Carcinoma.
Shirotake S; Takamatsu K; Mizuno R; Kaneko GO; Nishimoto K; Oya M; Oyama M
Anticancer Res; 2019 Aug; 39(8):4371-4377. PubMed ID: 31366532
[TBL] [Abstract] [Full Text] [Related]
